Oxford BioMedica PLC

Oxford Biomedica plc delivers lentiviral vector development and manufacturing via its LentiVector platform, serving pharma/biotech partners. Its Platform and Product segments support scalable gene‑therapy solutions, expanding into AAV and adenoviral vectors.

Headquarters: United Kingdom (GBR)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Family Planning Centers

Employees: 900
HQ: Oxford

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
OXB	Oxford BioMedica PLC Cap: 0.9B	EQUITY	LSE	GBP	GB00BDFBVT43	Active	📈